---
title: "LIFE: Stronger evidence, lower costs, and a NOK 25M capital raise drive improved Q2 2026 results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296304028.md"
description: "Q2 2026 saw strengthened real-world evidence, a clarified regulatory path, and a consolidated, lower-cost operating model. Financials improved with reduced expenses, a NOK 25 million capital raise, and a profit driven by warrant revaluation. Runway is expected through Q2 2027.Original document: Lifecare ASA [LIFE] Slides Release — Aug. 19 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-19T05:02:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296304028.md)
  - [en](https://longbridge.com/en/news/296304028.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296304028.md)
generator: "portal-rs"
---

# LIFE: Stronger evidence, lower costs, and a NOK 25M capital raise drive improved Q2 2026 results

Q2 2026 saw strengthened real-world evidence, a clarified regulatory path, and a consolidated, lower-cost operating model. Financials improved with reduced expenses, a NOK 25 million capital raise, and a profit driven by warrant revaluation. Runway is expected through Q2 2027.

Original document: Lifecare ASA \[LIFE\] Slides Release — Aug. 19 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [LIFE.US](https://longbridge.com/en/quote/LIFE.US.md)

## Related News & Research

- [OCEAN: Revenue fell, COOL launched, carbon capture scaled down, and liquidity improved after capital raise](https://longbridge.com/en/news/297862699.md)
- [Panoro Energy shares trade ex cash distribution of NOK 0.37 per share](https://longbridge.com/en/news/297733830.md)
- [ENSU: Record battery performance, cost reduction, and NOK 80M financing drive H1 2026 progress](https://longbridge.com/en/news/297464376.md)
- [Inven2 distributes NOK 2 million in commercialization income to researchers](https://longbridge.com/en/news/297624099.md)
- [CRNA: circVec platform achieved up to 60x gene expression, secured NOK 620M funding, and expanded R&D](https://longbridge.com/en/news/297674511.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**